A Study of KL340399 in Patients With Advanced Solid Tumors

Clinical trial NCT05387928 · COMPLETED

Trial details

NCT number: NCT05387928
Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2022-06-07
Primary completion: 2025-04-02
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.